Our performance at a glance
Intellectual capital
- Further reduced instances of product recalls achieving a
five-year low - Investment of over R444 million in modernising our digital capabilities with a further R749 million budgeted for FY2022
- 57 products launched in 17 countries and territories
Social and relationship capital
- Supported 200 social economic development ("SED") projects in 27 countries
- Advanced level of ethical culture as assessed by The Ethics Institute
- Aspen's 2020 Integrated Report was ranked as "excellent" by the EY Excellence in Integrated Reporting Awards
Manufactured capital
- R2 045 million invested in capital replacement and expansion projects
- Continued the production of life-saving medicines throughout the period of COVID-19 disruption
- Fast-tracked technical transfer and successfully commenced manufacture of the Johnson & Johnson COVID-19 vaccine
Financial capital
- Strong operating cash flow conversion rate of 134%
- Strengthened our balance sheet, achieving a leverage ratio of 1,7 times
- R6 351 million of wealth created reinvested in the Group
Natural capital
- "C Awareness" performance rating for 2020 Carbon Disclosure Project for Climate Change ("CDP-CC") and "B- Management" for Water Security ("CDP-WS")
- 82% of waste generated recycled
- 9% reduction in water withdrawn
Human capital
- R43,2 million invested in training our employees
- Zero occupational fatalities
- 26% women in top management roles in the Group
Revenue from continuing operations increased by
12% (10% CER)
to R37 766 million
Normalised EBITDA* from continuing operations increased by
3% (1% CER)
to R9 945 million
Normalised headline earnings per share (“NHEPS”) from continuing operations increased by
10% (7% CER)
to 1 309,7 cents
Net borrowings reduced to
R16 326 million
from R35 228 million
Resumption of dividends to shareholders of
262 cents per ordinary share
(2020: no dividend declared)| * | Normalised EBITDA comprises operating profit before depreciation and amortisation adjusted for specific non-trading items defined in accounting policies of the Group’s Annual Financial Statements. |
